Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Thursday, December 15, 2011

NIKE (NKE) (DIS) (OMN) (ONXX) (CRL) (CYTK) Ratings Reiterated

NIKE, Inc. (NYSE: NKE), Walt Disney (NYSE: DIS), OMNOVA Solutions Inc. (NYSE: OMN), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Charles River Laboratories (NYSE: CRL) and Cytokinetics, Inc. (NASDAQ: CYTK) had ratings on them reiterated by analysts.

Sterne Agee reiterated its "Buy” rating on NIKE, Inc. (NKE). They have a price target of $110.00 on the company.

Morgan Stanley (NYSE:MS) reiterated its "Overweight” rating on Walt Disney (DIS). They have a price target of $44.00 on the company.

Jefferies (NYSE:JEF) reiterated its "Buy” rating on OMNOVA Solutions Inc. (OMN). They have a price target of $6.00 on the company.

Brean Murray reiterated its "Hold” rating on Onyx Pharmaceuticals, Inc. (ONXX).

Deutsche Bank (NYSE:DB) reiterated its "Hold” rating on Charles River Laboratories (CRL).

Canaccord Genuity reiterated its "Buy” rating on Cytokinetics, Inc. (CYTK).

No comments: